- Home
- RVMD vs JLL Comparison
RVMD vs JLL Comparison
Compare RVMD & JLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVMD | JLL |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | United States |
| Employees | N/A | 48000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 16.8B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | RVMD | JLL |
|---|---|---|
| Price | $95.36 | $294.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 7 |
| Target Price | $117.33 | ★ $363.17 |
| AVG Volume (30 Days) | ★ 1.6M | 466.1K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.13 |
| EPS | N/A | ★ 16.40 |
| Revenue | N/A | ★ $26,115,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $454.85 | $6.83 |
| P/E Ratio | ★ N/A | $18.28 |
| Revenue Growth | N/A | ★ 11.45 |
| 52 Week Low | $29.17 | $194.36 |
| 52 Week High | $124.49 | $363.06 |
Technical Indicators
Market Signals| Indicator | RVMD | JLL |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 39.49 |
| Support Level | $93.86 | $281.92 |
| Resistance Level | $107.45 | $309.50 |
| Average True Range (ATR) | 3.19 | 9.98 |
| MACD | -0.30 | 0.73 |
| Stochastic Oscillator | 8.97 | 38.11 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $74 billion for clients across diverse public and private real estate strategies.